JUN 12, 2018 3:39 PM PDT

Auto-antibody Detection for Rheumatoid Arthritis Patients

WRITTEN BY: Kara Marker

No case of rheumatoid arthritis (RA), an autoimmune disease, is the same. Now, researchers want RA diagnostic approaches to match its pathological diversity. From Uppsala University, scientists demonstrate the importance of a broad diagnostic approach to identifying cases of RA.

Histology section from rheumatoid arthritis tissue, showing inflammation and joint damage. Credit: Jensflorian

“RA patients with and without ACPA probably have different diseases with separate causes, but start with a similar clinical picture," explained research team leader Johan Rönnelid.

ACPAs, or anti-citrullinated protein antibodies, are produced by the immune system as part of the autoimmune response present in RA. Autoimmune diseases affecting different body tissues and systems are all caused by the body’s accidental attack on its own tissues, responding as if the tissues were pathogenic. A key part of this autoimmune response is the production of “auto-antibodies,” like ACPAs, that target the body’s own proteins, like the amino acid citrulline, as opposed to targeting bacterial or viral proteins.

RA is an autoimmune disease characterized by chronic inflammation in the joints and other parts of the body. Inflammation in the joints causes tissue to thicken, resulting in swelling and pain experienced by RA patients. The disease often affects the hands, feet, wrists, elbows, knees, and ankles. Approximately 1.5 million people are diagnosed with RA in the United States, disproportionately women.

Researchers from the present study are dedicated to improving RA diagnosis with a new technique that measures a variety of citrulline antibodies. Looking for a variety of citrulline antibodies as opposed to one type or just a few types will help scientists detect severe inflammation and joint damage.

A broader test is necessary to detect the various proteins and protein fragments that are targeted in each case of RA. No case is the same, so the test has to account for all of the possibilities. The test looks for various auto-antibodies, which bind to host proteins and form immune complexes that then trigger inflammation that leads to the physical symptoms experienced by RA patients. The current study is the first to observe ACPA immune complexes in body fluids from RA patients.

ACPAs are produced as a result of RA-mediated inflammation, and they are observed in more than half of all RA patients, but not all. In the past, researchers have identified genetic differences between patients with and without these antibodies. Additionally, ACPA-positive RA cases are linked to patients who smoke, and ACPA-positive patients have more joint inflammation than ACPA-negative RA patients.

Researchers developed the new test by first extracting immune complexes from different types of body fluid (serum, synovial fluid, immune complexes) from 77 RA patients, then measuring 19 different ACPAs. They found that no single ACPA stood out from the rest. In fact, a broader range of ACPAs in immune complexes are responsible for driving inflammation and joint damage characteristic of RA.

The present study was published in the journal Annals of the Rheumatic Diseases.

Sources: Arthritis Foundation, Uppsala University

About the Author
  • I am a scientific journalist and enthusiast, especially in the realm of biomedicine. I am passionate about conveying the truth in scientific phenomena and subsequently improving health and public awareness. Sometimes scientific research needs a translator to effectively communicate the scientific jargon present in significant findings. I plan to be that translating communicator, and I hope to decrease the spread of misrepresented scientific phenomena! Check out my science blog: ScienceKara.com.
You May Also Like
DEC 15, 2020
Immunology
Immunity-Boosting: Is It Real?
DEC 15, 2020
Immunity-Boosting: Is It Real?
The question everyone tries to find an answer to in the winter season is how can we improve our immunity to fight any in ...
JAN 13, 2021
Immunology
Antibodies Gain the Upper Hand Against Sly Tumors
JAN 13, 2021
Antibodies Gain the Upper Hand Against Sly Tumors
Tumors use ingenious approaches to stay just out of reach of immune cells on patrol and avoid detection. Indeed, cancer ...
FEB 02, 2021
Immunology
Tumors Under Seige by Cancer-Killing Salmonella
FEB 02, 2021
Tumors Under Seige by Cancer-Killing Salmonella
Salmonella is a genus of rod-shaped bacteria, often given a bad rap thanks to its association with food poisoning. But c ...
MAR 02, 2021
Immunology
Another Trick up Tumors' Sleeves Exposed
MAR 02, 2021
Another Trick up Tumors' Sleeves Exposed
Tumors have sneaky strategies for establishing themselves within healthy tissues, flourishing in plain sight of circulat ...
MAR 04, 2021
Immunology
Why Do We Need Two Shots of the COVID Vaccine?
MAR 04, 2021
Why Do We Need Two Shots of the COVID Vaccine?
Unlike social distancing, mask-wearing, and hand hygiene, vaccines are our best bet as a long-term solution to protectin ...
APR 06, 2021
Cell & Molecular Biology
New Insight Into a Crucial Immune Cell
APR 06, 2021
New Insight Into a Crucial Immune Cell
Dendritic cells are a crucial part of the immune response; they look out for the presence of pathogenic invaders like vi ...
Loading Comments...